Quarterly report [Sections 13 or 15(d)]

Shareholders' Equity (Deficit)

v3.25.2
Shareholders' Equity (Deficit)
6 Months Ended
Jun. 30, 2025
Shareholders' Equity (Deficit)  
Shareholders' Equity (Deficit)

13. Shareholders' Equity (Deficit)

LP Units of JJ LP

The limited partnership units (“LP Units”) of JJ LP, a subsidiary of the Company, are exchangeable for one common share at any time per request of the owner of the LP Units and are not saleable or transferable without the Company’s authorization. During each of the six months ended June 30, 2025 and 2024, there were no LP Units of JJ LP converted to common shares. As of each of June 30, 2025 and December 31, 2024, 43,821,379 LP Units of JJ LP were issued and outstanding.

Warrants

In connection with the NPA Amendment, the Company issued 91,999,901 Debt Modification Warrants. Each Debt Modification Warrant is exercisable at any time prior to its expiration for one common share of the Company at an exercise price of $0.07084 per common share. The Debt Modification Warrants expire on February 15, 2030 and contain customary anti-dilution adjustment provisions.

The fair value of the Debt Modification Warrants upon issuance was determined using the Black-Scholes option pricing model with the following assumptions:

Exercise price

    

$

0.07084

Expected dividend yield

0%

Risk-free interest rate

3.94%

Expected life in years

7.0 years

Expected volatility

84.00%

The following table summarizes the warrants that remain outstanding as of June 30, 2025:

Exercise

Number of

Security issued

    

Price (CAD$)

    

Warrants

    

Expiration Date

Debt modification warrants

0.09

91,999,901

February 15, 2030

91,999,901

There was no warrant activity during the six months ended June 30, 2025.

Share-based Compensation

Under the Amended and Restated 2018 Stock and Incentive Plan (the “2018 Plan”), the Company has reserved 60,000,000 common shares to be issued as awards to employees, management, directors and consultants of the Company, as designated by the Company’s board of directors (the “Board”) or the compensation committee of the Board. “Award” is defined in the 2018 Plan to include options, stock appreciation rights, restricted stocks, restricted stock units, performance stock units, dividend equivalents and stock-based awards. As of June 30, 2025, 16,728,529 common shares are available for issuance under the 2018 Plan.

Restricted Stock Units (“RSUs”)

A summary of the status of the RSUs outstanding is as follows:

Number of

Weighted Average

RSUs

    

RSUs

    

Grant Date Fair Value

Unvested as of December 31, 2024

715,252

$

0.03

Vested

(68,683)

0.03

Forfeited

(148,349)

0.03

Unvested as of June 30, 2025

498,220

$

0.03

During the three months ended June 30, 2025 and 2024, the Company recorded $1 of share-based compensation benefit and $23 of share-based compensation expense, respectively, relating to RSUs. During the six months ended June 30, 2025 and 2024, the Company recorded $1 and $71 of share-based compensation expense, respectively.

As of June 30, 2025, there was $4 of remaining RSU expense to be recognized over the weighted average remaining period of 0.94 years.

Share Options

A summary of the status of the share options outstanding is as follows:

Share Options

Weighted

Weighted Average

Common

Average

Remaining Contractual

Share options

    

Shares

    

Exercise Price

    

Life (yrs)

Balance as of December 31, 2024

26,693,855

$

0.12

8.78

Forfeited

(243,281)

0.43

Balance as of June 30, 2025

26,450,574

$

0.12

8.31

For the three months ended June 30, 2025 and 2024, the Company recorded share-based compensation expense of $16 and $3, respectively, related to these options. For the six months ended June 30, 2025 and 2024, the Company recorded share-based compensation expense of $79 and $20, respectively, related to these options.

On September 29, 2024, the Company entered into an independent director compensation agreement that approved the issuance of 27,878,788 options to four members of the Board, with each member granted 6,969,697 share options. These options were issued at a weighted-average grant date fair value of $0.0143. Share-based compensation expense of $21 and $84 was recognized related to these options during the three and six months ended June 30, 2025, respectively. As of June 30, 2025, 20,909,091 options vested, with each Board member receiving 6,969,697 options. Additionally, one of the grantees departed the Board, resulting in forfeiture of 5,227,273 options. As of June 30, 2025, all options had vested or been forfeited and there is no remaining expense to be recognized.

The following table summarizes the share options that remain outstanding as of June 30, 2025:

Number of

Exercise

Options

Security issuable

    

Share Options

    

Price

    

Expiration Date

    

Exercisable

Legacy employees

190,000

$ 1.58-1.58

June 28, 2028

190,000

2020 employee grant

3,666,066

$ 0.30-0.48

June 25, 2030 - December 1, 2030

3,636,083

Other employee grants

22,594,508

$ 0.02-3.96

February 14, 2029 - September 29, 2034

22,594,508

Total

26,450,574

26,420,591

Performance Stock Units (“PSUs”)

During the six months ended June 30, 2025, 700,000 PSUs were forfeited, and there were no PSUs outstanding as of June 30, 2025.

As there was no PSU activity during the six months ended June 30, 2025, no share-based compensation expense was recognized for this period. During the three and six months ended June 30, 2024, the Company recorded share-base compensation benefit of $3 and share-based compensation expense of $39 relating to PSUs.

On September 26, 2023, the Company entered into an employment agreement with Tim Conder, the Company’s Chief Executive Officer (“CEO”) (the “CEO Agreement”) pursuant to which Mr. Conder serves as the CEO of the Company. Under the terms of the CEO Agreement, Mr. Conder received an equity grant of 2,000,000 PSUs under the 2018 Plan of which up to 1,000,000 PSUs would vest upon the Board’s approval of whether metrics set forth in the CEO Agreement had been achieved as of December 31, 2023. On April 19, 2024, the Board determined that two-thirds of the metrics set forth in the CEO Agreement had been achieved as of December 31, 2023 and Mr. Conder is entitled to 666,666 PSUs. On April 19, 2024, the Company also entered into a side letter with Mr. Conder pursuant to which Mr. Conder agreed that the 666,666 PSUs would vest on June 30, 2024. These PSUs vested per the side letter on June 30, 2024. The remaining 700,000 options were forfeited during the six months ended June 30, 2025.

As of June 30, 2025, all PSU awards granted containing market conditions have expired and there is no remaining expense to be recognized.